Edition:
United Kingdom

Jiangsu Lianhuan Pharmaceutical Co Ltd (600513.SS)

600513.SS on Shanghai Stock Exchange

8.26CNY
18 May 2018
Change (% chg)

¥-0.13 (-1.55%)
Prev Close
¥8.39
Open
¥8.33
Day's High
¥8.38
Day's Low
¥8.10
Volume
6,052,122
Avg. Vol
2,722,599
52-wk High
¥10.89
52-wk Low
¥7.24

Latest Key Developments (Source: Significant Developments)

Jiangsu Lianhuan Pharmaceutical to pay annual cash div as 0.75 yuan per 10 shares for FY 2017
Friday, 13 Apr 2018 

April 13(Reuters) - Jiangsu Lianhuan Pharmaceutical Co Ltd <600513.SS> : :* Says it plans to pay annual cash dividend as 0.75 yuan(pre-tax) per 10 shares as FY 2017 div payment.  Full Article

Jiangsu Lianhuan Pharmaceutical to set up new energy unit in Yangzhou
Friday, 29 Dec 2017 

Dec 29(Reuters) - Jiangsu Lianhuan Pharmaceutical Co Ltd <600513.SS>:Says it plans to invest 20 million yuan to set up a wholly owned new energy unit in Yangzhou .  Full Article

Jiangsu Lianhuan Pharmaceutical to pay 2015 div on July 6
Thursday, 30 Jun 2016 

Jiangsu Lianhuan Pharmaceutical <600513.SS> Co., Ltd.: Says it will pay a cash dividend of 0.6 yuan (before tax) per 10 shares and use additional paid-in capital to distribute 3 new share for every 10 shares, to shareholders of record on July 5 for 2015 .Says the company's shares will be traded ex-right and ex-dividend on July 6 and the dividend will be paid on July 6.  Full Article

Jiangsu Lianhuan Pharmaceutical unit passes FDA approval
Tuesday, 28 Jun 2016 

Jiangsu Lianhuan Pharmaceutical Co., Ltd. <600513.SS>: Says its unit receives approval for its seven drug production lines including hydrocortisone, from U.S Food and Drug Administration .Says the unit will be able to sell its drugs in the United States after receiving the FDA approval.  Full Article

BRIEF-Jiangsu Lianhuan Pharmaceutical Elects Chairman

* SAYS BOARD ELECTS XIA CHUNLAI AS CHAIRMAN Source text in Chinese: https://bit.ly/2jpfSwf Further company coverage: (Reporting by Hong Kong newsroom)

No consensus analysis data available.